Roopa Shivashankar1, Katy Kirk2, Woon Cho Kim3, Chaturia Rouse4, Nikhil Tandon5, K M Venkat Narayan6, Mahammed K Ali6. 1. Centre for Chronic Disease Control, New Delhi, India; Public Health Foundation of India, New Delhi, India. Electronic address: roopa@ccdcindia.org. 2. Brody School of Medicine at East Carolina University, Greenville, NC, USA. 3. Emory University School of Medicine, Atlanta, GA, USA. 4. Center for Disease Control and Prevention, Atlanta, GA, USA. 5. All India Institute of Medical Sciences, New Delhi, India. 6. Rollins School of Public Health, Emory University, Atlanta, GA, USA.
Abstract
OBJECTIVE: To assess the extent to which people with diabetes in low- and middle-income countries (LMIC) of Asia and the Middle East met evidence-based care recommendations through a systematic review of published literature. METHODS: Electronic searches of Medline and Embase were carried out for studies assessing quality of care among people with diabetes in Asia and the Middle East between 1993 and 2012. Benchmarking against American Diabetes Association guidelines, we reported level and proportions meeting recommended risk factor control (glycated hemoglobin [HbA1c], blood pressure, and low density lipoprotein-cholesterol [LDL]) and preventive care processes across different settings. RESULTS: One hundred and fifteen publications met eligibility for inclusion (91 reported risk factor control, 7 reported preventive processes, and 17 reported both). Only China, Thailand, Malaysia and Philippines had nationally representative data. Mean HbA1c (6.5-11% or 48-97 mmol/mol), SBP (120-152 mm Hg), and LDL (2.4-3.8 mmol/l) varied greatly. Despite variation in availability of data, studies consistently showed that recommended care goals were not being achieved. CONCLUSIONS: The practice of auditing and benchmarking against evidence-based guidelines appears to be uncommon in Asia and the Middle East and there was heterogeneity of reporting across studies, populations, and methods used. The available data showed inadequate care.
OBJECTIVE: To assess the extent to which people with diabetes in low- and middle-income countries (LMIC) of Asia and the Middle East met evidence-based care recommendations through a systematic review of published literature. METHODS: Electronic searches of Medline and Embase were carried out for studies assessing quality of care among people with diabetes in Asia and the Middle East between 1993 and 2012. Benchmarking against American Diabetes Association guidelines, we reported level and proportions meeting recommended risk factor control (glycated hemoglobin [HbA1c], blood pressure, and low density lipoprotein-cholesterol [LDL]) and preventive care processes across different settings. RESULTS: One hundred and fifteen publications met eligibility for inclusion (91 reported risk factor control, 7 reported preventive processes, and 17 reported both). Only China, Thailand, Malaysia and Philippines had nationally representative data. Mean HbA1c (6.5-11% or 48-97 mmol/mol), SBP (120-152 mm Hg), and LDL (2.4-3.8 mmol/l) varied greatly. Despite variation in availability of data, studies consistently showed that recommended care goals were not being achieved. CONCLUSIONS: The practice of auditing and benchmarking against evidence-based guidelines appears to be uncommon in Asia and the Middle East and there was heterogeneity of reporting across studies, populations, and methods used. The available data showed inadequate care.
Authors: Mohammed K Ali; Kavita Singh; Dimple Kondal; Raji Devarajan; Shivani A Patel; Roopa Shivashankar; Vamadevan S Ajay; A G Unnikrishnan; V Usha Menon; Premlata K Varthakavi; Vijay Viswanathan; Mala Dharmalingam; Ganapati Bantwal; Rakesh Kumar Sahay; Muhammad Qamar Masood; Rajesh Khadgawat; Ankush Desai; Bipin Sethi; Dorairaj Prabhakaran; K M Venkat Narayan; Nikhil Tandon Journal: Ann Intern Med Date: 2016-07-12 Impact factor: 25.391
Authors: David Flood; Pascal Geldsetzer; Kokou Agoudavi; Krishna K Aryal; Luisa Campos Caldeira Brant; Garry Brian; Maria Dorobantu; Farshad Farzadfar; Oana Gheorghe-Fronea; Mongal Singh Gurung; David Guwatudde; Corine Houehanou; Jutta M Adelin Jorgensen; Dimple Kondal; Demetre Labadarios; Maja E Marcus; Mary Mayige; Mana Moghimi; Bolormaa Norov; Gastón Perman; Sarah Quesnel-Crooks; Mohammad-Mahdi Rashidi; Sahar Saeedi Moghaddam; Jacqueline A Seiglie; Silver K Bahendeka; Eric Steinbrook; Michaela Theilmann; Lisa J Ware; Sebastian Vollmer; Rifat Atun; Justine I Davies; Mohammed K Ali; Peter Rohloff; Jennifer Manne-Goehler Journal: Diabetes Care Date: 2022-09-01 Impact factor: 17.152
Authors: David Flood; Jacqueline A Seiglie; Matthew Dunn; Scott Tschida; Michaela Theilmann; Maja E Marcus; Garry Brian; Bolormaa Norov; Mary T Mayige; Mongal Singh Gurung; Krishna K Aryal; Demetre Labadarios; Maria Dorobantu; Bahendeka K Silver; Pascal Bovet; Jutta M Adelin Jorgensen; David Guwatudde; Corine Houehanou; Glennis Andall-Brereton; Sarah Quesnel-Crooks; Lela Sturua; Farshad Farzadfar; Sahar Saeedi Moghaddam; Rifat Atun; Sebastian Vollmer; Till W Bärnighausen; Justine I Davies; Deborah J Wexler; Pascal Geldsetzer; Peter Rohloff; Manuel Ramírez-Zea; Michele Heisler; Jennifer Manne-Goehler Journal: Lancet Healthy Longev Date: 2021-05-21
Authors: T K Pruthu; Marie Gilbert Majella; Divya Nair; Gomathi Ramaswamy; C Palanivel; L Subitha; S Ganesh Kumar; Sitanshu Sekhar Kar Journal: J Nat Sci Biol Med Date: 2015-08